We will use cookies and other information to optimize your experience. By continuing to browse, you consent to our use. For details, please read
Privacy Policy
×
Gongwin Biopharm Co., Ltd.
Language
繁體中文
English
About Us
Company Profile
History
Our Team
Partnership
News&Media
Press Release
Recent Activity
Events
Latest news
Pipeline
Products
Product Features
PTS302 NSCLC-SMAO
Medical column
Treatment Result or Case
Pipeline development milestones
PTS100 HCC
Medical column
Treatment Result or Case
Clinical Trials
Pipeline development milestones
PTS-02 ACC
Medical column
Treatment Result or Case
Pipeline development milestones
PTS500 MPE
Medical column
Treatment Result or Case
Pipeline development milestones
Anti-tumor drug for canine use
Superficial malignant tumor in canine
Malignant melanoma of the canine
Lipoma of the canine and feline
Malignant bladder tumor of the canine and feline
R & D
Core Technology
Mechanism of Action
R & D Center
Published Paper
Investors
Financial information
Company annual report
Financial report
Monthly revenue
Legal person briefing
Corporate Governance
Corporate governance structure
Board of Directors
Committee
Internal audit
Company regulations
Other corporate governance information
Shareholder area
Shareholders' meeting
Dividend distribution
Material message
Stock price message
Investor Relations Contact Window
Stock agency
Interest relationship
Interested parties communicate with the company
Video
Contact
Home
隱私權政策
隱私權政策
繁體中文
English
Language
繁體中文
English
About Us
Company Profile
History
Our Team
Partnership
News&Media
Press Release
Recent Activity
Events
Latest news
Pipeline
Products
Product Features
PTS302 NSCLC-SMAO
Medical column
Treatment Result or Case
Pipeline development milestones
PTS100 HCC
Medical column
Treatment Result or Case
Clinical Trials
Pipeline development milestones
PTS-02 ACC
Medical column
Treatment Result or Case
Pipeline development milestones
PTS500 MPE
Medical column
Treatment Result or Case
Pipeline development milestones
Anti-tumor drug for canine use
Superficial malignant tumor in canine
Malignant melanoma of the canine
Lipoma of the canine and feline
Malignant bladder tumor of the canine and feline
R & D
Core Technology
Mechanism of Action
R & D Center
Published Paper
Investors
Financial information
Company annual report
Financial report
Monthly revenue
Legal person briefing
Corporate Governance
Corporate governance structure
Board of Directors
Committee
Internal audit
Company regulations
Other corporate governance information
Shareholder area
Shareholders' meeting
Dividend distribution
Material message
Stock price message
Investor Relations Contact Window
Stock agency
Interest relationship
Interested parties communicate with the company
Video
Contact
